Report cover image

Coronary Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Apr 29, 2024
Length 74 Pages
SKU # GBDT18798849

Description

Coronary Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Coronary Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). The guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: central core, outer covering and flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on guidewire may be either hydrophilic or hydrophobic.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Coronary Guidewires under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Guidewires under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

74 Pages
  • About GlobalData
    • Coronary Guidewires Overview
    • Coronary Guidewires - Pipeline Products by Stage of Development
    • Coronary Guidewires - Pipeline Products by Territory
    • Coronary Guidewires - Pipeline Products by Regulatory Path
    • Coronary Guidewires - Pipeline Products by Estimated Approval Date
    • Coronary Guidewires - Ongoing Clinical Trials
    • Coronary Guidewires Companies - Pipeline Products by Stage of Development
    • Coronary Guidewires – Companies Pipeline Products by Stage of Development
    • Abbott Vascular Inc Company Overview
    • AdenoPaint LLC Company Overview
    • APT Medical Inc Company Overview
    • Bioscan Technologies Inc. Company Overview
    • Boston Scientific Corp Company Overview
    • Cardiovascular Systems Inc Company Overview
    • CorMetrics LLC Company Overview
    • Echopoint Medical Ltd Company Overview
    • ENDOMATERIALS Company Overview
    • Georgia Institute of Technology Company Overview
    • Guided Interventions, LLC Company Overview
    • Infrared Sciences Corp Company Overview
    • Koninklijke Philips NV Company Overview
    • Microbot Medical Ltd Company Overview
    • MicroPort Scientific Corp Company Overview
    • NewMed Medical Co Ltd Company Overview
    • Nirtek Pty Ltd Company Overview
    • Opsens Inc Company Overview
    • OVALUM Ltd Company Overview
    • SoundBite Medical Solutions Inc Company Overview
    • St. Jude Medical LLC Company Overview
    • Terumo Corp Company Overview
    • Terumo Interventional Systems Company Overview
    • The Cleveland Clinic Foundation Company Overview
    • Three Rivers Cardiovascular Systems Inc Company Overview
    • Transmural systems LLC Company Overview
    • University of Illinois at Chicago Company Overview
    • Vasostar Ltd. Company Overview
    • Xenter Inc Company Overview
    • Apr 04, 2024: AngioDynamics Reports Results for the Quarter Ended In February
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Feb 28, 2024: Merit Medical Introduces 'Continued Growth Initiatives' Program and Financial Targets for Three-Year Period Ending December 31, 2026
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
    • Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF 232.27 KB)
    • Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
    • Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning
    • Nov 10, 2023: Microport Appointment of Director
    • Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
    • Oct 23, 2023: OPSENS Announces the Positive Clinical Results from the SAFE-TAVI Study with Savvywire in Europe
    • Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
    • Oct 17, 2023: Opsens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) In San Francisco October 23 - 26, 2023
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
    • Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
    • Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Aug 07, 2023: Cleveland Clinic Appoints Albert Marinez as its First Chief Analytics Officer
    • Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
    • Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
    • Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
    • May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023
    • May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
    • May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • May 10, 2023: Opsens announces inclusion of Savvywire in complete TAVR study
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us